Sensitivity of insulin secretion to GLP-1 is clinically important because of the reduced incretin effect in T2DM patients [38], a finding recently proposed to extend to obese subjects [37,39]. The gene discussed is GLP1R; the disease is type 2 diabetes mellitus.